Breast Cancer Survivors Benefit From Yoga

Share this content:
Breast Cancer Survivors Benefit From Yoga
Breast Cancer Survivors Benefit From Yoga

(HealthDay News) — For breast cancer survivors, a 12-week yoga intervention improves fatigue and vitality and is associated with reduced levels of proinflammatory cytokines, according to a study published online Jan. 27 in the Journal of Clinical Oncology.

Janice K. Kiecolt-Glaser, Ph.D., from The Ohio State University in Columbus, and colleagues examined the impact of yoga on inflammation, mood, and fatigue in a randomized three-month controlled trial involving 200 breast cancer survivors. Participants were randomized to 12-week, twice-weekly, 90-minute hatha yoga classes or wait-list control.

RELATED: Breast Cancer Resource Center

The researchers found that, immediately post-treatment, vitality was higher (P = 0.01) in the yoga versus the control group, although fatigue was not lower (P > 0.05). At 3 months post-treatment, participants in the yoga group had lower fatigue (P = 0.002), higher vitality (P = 0.01), and lower levels of interleukin (IL)-6, tumor necrosis factor α (TNF-α), and IL-1β (P = 0.027, 0.027, and 0.037, respectively), compared with controls. No difference was seen in depression at either time point (P > 0.2). 

In a planned secondary analysis, at both post-treatment visits, yoga practice frequency was more strongly associated with fatigue (P = 0.019 and 0.0001) and vitality (P = 0.016 and 0.0045), but not depression (P > 0.05), than simple group assignment. Larger changes were seen with more frequent practice. Increasing yoga practice also correlated with decreased IL-6 and IL-1β production (P = 0.01 and 0.03, respectively), but not with TNF-α (P > 0.05).

"If yoga dampens or limits both fatigue and inflammation, then regular practice could have substantial health benefits," the researchers wrote.

References

  1. Kiecolt-Glaser JK, Bennett JM, Andridge R, et al. Yoga's Impact on Inflammation, Mood, and Fatigue in Breast Cancer Survivors: A Randomized Controlled Trial. J Clin Oncol. 2014;doi:10.1200/JCO.2013.51.8860.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs